https://www.natureworldnews.com/articles/5050/20131123/fda-approves-johnson-johnsons-olysio-treatment-hepatitis-c-virus-infection.htm
The U.S. Food and Drug Administration has approved Johnson & Johnson's 'Olysio' for treating hepatitis C virus infection, the agency announced Friday.
hepatitis c virusfdajohnsonolysio
https://www.news-medical.net/news/20131123/FDA-approves-OLYSIO-%28simeprevir%29-for-treatment-of-chronic-hepatitis-C-infection.aspx
Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A...
chronic hepatitisfdaolysiosimeprevirtreatment